CN Patent
CN107115329A — 一种复方布替萘芬制剂及其应用
Assigned to No2 Affiliated Hospital Of Second Military Medical University Pla · Expires 2017-09-01 · 9y expired
What this patent protects
本发明涉及医药技术领域,具体是一种复方布替萘芬制剂,该制剂的活性成份为盐酸布替萘芬和糠酸莫米松。本发明的复方布替萘芬制剂适用于治疗炎症性浅表皮肤真菌病,其疗效高,起效快,安全性好,同时激素副反应小,且无明显过敏反应以及激素副作用。
USPTO Abstract
本发明涉及医药技术领域,具体是一种复方布替萘芬制剂,该制剂的活性成份为盐酸布替萘芬和糠酸莫米松。本发明的复方布替萘芬制剂适用于治疗炎症性浅表皮肤真菌病,其疗效高,起效快,安全性好,同时激素副反应小,且无明显过敏反应以及激素副作用。
Drugs covered by this patent
- Jublia (EFINACONAZOLE) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.